NVO

NYSE · Equity

Novo Nordisk A/S

US Healthcare Drug Manufacturers - General

Latest week
29 May 2026
Close
45.580000
Fair value
81.972963
Expectation
Undecided 47.95%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
45.58
12-Week Change
24.22%
Trend Signal
Inactive
Expectation
Undecided 47.95%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-21.95
Market Dynamics
0.47

Over the latest 12 completed weeks ending 2026-05-29, NVO rose 24.22%, moving from 36.69 to 45.58. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -21.95 and has improved across the 12-week window. Market Dynamics is 0.47 on the latest week. Expectation is undecided at 47.95%.